The Nebraska Medical Association

https://www.nebmed.org/

 

The Nebraska Medical Association
T

Mediators of Cardiovascular Risk Reduction With MTX Use in Rheumatoid Arthritis

By The Nebraska Medical Association FEATURING Tate Johnson
By The Nebraska Medical Association FEATURING Tate Johnson
50 views
June 21, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
Nebraska Rheumatology Society
69:57
The Nebraska Medical Association

SARS-CoV-2 Vaccination in Autoimmune Diseases: Updates on Immunogeni…

Feat. A. Kim
24:00
The Nebraska Medical Association

Updates on Gout: Epidemiology, Cause-Specific Mortality, & Medi…

Feat. L. Helget
16:47
The Nebraska Medical Association

Nebraska Medical Association Legislative Update 2022

Feat. D. Schrodt
11:48
The Nebraska Medical Association

Nebraska Medical Association Legislative Update 2021

Feat. D. Schrodt
13:13
The Nebraska Medical Association

Mediators of Cardiovascular Risk Reduction With MTX Use in Rheumatoi…

Feat. T. Johnson
12:37
The Nebraska Medical Association

Nebraska Rheumatology Society COVID-19 Update 2021: Vaccination

Feat. T. Mikuls
26:20
Nebraska Rheumatology Society

2020 Update on Behcet's Syndrome: What Are ISG Criteria of Cond…

Feat. Y. Yazici
12:06
Nebraska Rheumatology Society

Behcet's Syndrome 2020 Update: What Is the Efficacy of TNF Anto…

Feat. Y. Yazici